These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 32568052)

  • 1. Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.
    Chen YC; Hsu WY; Chang TH
    Emerg Infect Dis; 2020 Jul; 26(7):1382-1391. PubMed ID: 32568052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
    Wang YS; Zhou YL; Bai GN; Li SX; Xu D; Chen LN; Chen X; Dong XY; Fu HM; Fu Z; Hao CL; Hong JG; Liu EM; Liu HM; Lu XX; Luo ZX; Tang LF; Tian M; Yin Y; Zhang XB; Zhang JH; Zhang HL; Zhao DY; Zhao SY; Zhu GH; Zou YX; Lu Q; Zhang YY; Chen ZM
    World J Pediatr; 2024 Sep; 20(9):901-914. PubMed ID: 39143259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA.
    Lanata MM; Wang H; Everhart K; Moore-Clingenpeel M; Ramilo O; Leber A
    Emerg Infect Dis; 2021 Jun; 27(6):1588-1597. PubMed ID: 34013867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant
    Choi JH; Seong GM; Ko Y; Kim YR; Kim C
    Microb Drug Resist; 2019 May; 25(4):577-581. PubMed ID: 30484744
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.
    Lung DC; Yip EK; Lam DS; Que TL
    Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.
    Cheong KN; Chiu SS; Chan BW; To KK; Chan EL; Ho PL
    J Microbiol Immunol Infect; 2016 Feb; 49(1):127-30. PubMed ID: 25556047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance of macrolide resistance in pediatric
    Jiang TT; Sun L; Wang TY; Qi H; Tang H; Wang YC; Han Q; Shi XQ; Bi J; Jiao WW; Shen AD
    Front Cell Infect Microbiol; 2023; 13():1181402. PubMed ID: 37249975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of variables associated with prolonged admission duration in children with Mycoplasma pneumoniae pneumonia.
    Sung M; Roh EJ; Lee ES; Lee JY; Kim HB; Ahn Y; Eun BW; Kim JK; Kim HY; Jung SS; Kim M; Kang EK; Yang EA; Lee SJ; Park Y; Seo JH; Lee E; Yang ES; Cho HM; Shin M; Chung HL; Jang YY; Choi BS; Kim H; Jung JA; You ST; Lee MH; Kim JT; Kim BS; Hwang YH; Shim JY; Yang HJ; Han MY; Yew HY; Kim DH; Jeong SO; Whang K; Lee E; Jeon YH; Chung EH
    Clin Respir J; 2022 Nov; 16(11):756-767. PubMed ID: 36205104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis.
    Ahn JG; Cho HK; Li D; Choi M; Lee J; Eun BW; Jo DS; Park SE; Choi EH; Yang HJ; Kim KH
    BMC Infect Dis; 2021 Sep; 21(1):1003. PubMed ID: 34563128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.
    Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Togashi T; Oba K; Morita K; Nagano N; Nakanishi M; Hara K; Hazama K; Watanabe T; Yamanaka T; Sasaki S; Furuyama H; Shibata M; Shida S; Ishizaka A; Tabata Y; Aoyagi H; Naito H; Yoshioka M; Horino A; Kenri T;
    PLoS One; 2017; 12(3):e0173635. PubMed ID: 28288170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.
    Waites KB; Ratliff A; Crabb DM; Xiao L; Qin X; Selvarangan R; Tang YW; Zheng X; Dien Bard J; Hong T; Prichard M; Brooks E; Dallas S; Duffy L; Mixon E; Fowler KB; Atkinson TP
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31484701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
    Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
    J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.
    Ho PL; Law PY; Chan BW; Wong CW; To KK; Chiu SS; Cheng VC; Yam WC
    J Clin Microbiol; 2015 Nov; 53(11):3560-4. PubMed ID: 26338857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases.
    Li P; Wang W; Zhang X; Pan J; Gong L
    Sci Rep; 2024 Mar; 14(1):5632. PubMed ID: 38453960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
    Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
    BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of and the factors associated with macrolide resistance and poor macrolide response in pediatric Mycoplasma pneumoniae infection: A retrospective study.
    Yen MH; Yan DC; Wang CJ; Tsao KC; Huang YC; Cheng SW; Chiu CH; Huang YC; Lin TY
    J Microbiol Immunol Infect; 2023 Jun; 56(3):634-640. PubMed ID: 36737359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.
    Ding G; Zhang X; Vinturache A; van Rossum AMC; Yin Y; Zhang Y
    Eur J Pediatr; 2024 Jul; 183(7):3001-3011. PubMed ID: 38634891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase-shifting of the transmissibility of macrolide-sensitive and resistant Mycoplasma pneumoniae epidemics in Hong Kong, from 2015 to 2018.
    Zhao S; Musa SS; Qin J; He D
    Int J Infect Dis; 2019 Apr; 81():251-253. PubMed ID: 30822543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland.
    Meyer Sauteur PM; Bleisch B; Voit A; Maurer FP; Relly C; Berger C; Nadal D; Bloemberg GV
    Swiss Med Wkly; 2014; 144():w14041. PubMed ID: 25254315
    [No Abstract]   [Full Text] [Related]  

  • 20. Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae.
    Morozumi M; Okada T; Tajima T; Ubukata K; Iwata S
    Int J Antimicrob Agents; 2017 Aug; 50(2):255-257. PubMed ID: 28579455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.